State it in the SAP & observe it [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2021-03-29 16:08 (18 d 13:21 ago) – Posting: # 22298
Views: 308

Hi Loky do,

» If subject during bioequivalence study suffered from diarrhea before 2 median Tmax of immediate-release drug product, in this case, the optimum action to be done to exclude the subject from the study after the event directly?

If you know the median tmax:-D Sometimes in the label / SmPC for unfathomable reasons the mean is given.
State in the statistical analysis plan, and follow it (analyse the samples anyway).

» or subject continues the study and excludes his results from the calculations if his plasma concentration-time profile is unreliable?

I would not recommend that. Who / how decides what is ‘unreliable’? May lead to endless & fruitless discussions.

Dif-tor heh smusma 🖖
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

 Admin contact
21,419 posts in 4,475 threads, 1,508 registered users;
online 14 (0 registered, 14 guests [including 3 identified bots]).
Forum time: Saturday 05:29 UTC (Europe/Vienna)

I never did anything worth doing by accident,
nor did any of my inventions come by accident;
they came by work.    Thomas Alva Edison

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz